<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Deregulated myc, bcl-2 and/or TP53 gene expression is associated with non-Hodgkin's B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (B-NHLs) </plain></SENT>
<SENT sid="1" pm="."><plain>Emu-N-myc transgenic mice that misexpress N-myc protein and carry a non-disrupted bcl-2 gene develop indolent B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> reminiscent of the B-NHL, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> from mice with <z:e sem="disease" ids="C0679247" disease_type="Disease or Syndrome" abbrv="">end-stage disease</z:e> exhibited discrete, nodular lesions as well as areas of diffuse <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> likely due to coalescence of enlarged follicles </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> DNAs were screened for mutations in the Trp53 gene, the murine homologue of the TP53 gene, which participates in B cell differentiation and survival </plain></SENT>
<SENT sid="4" pm="."><plain>By PCR-based sequence analyses, we determined there were no mutations in exons 5-8, the common sites of TP53 mutation in B-NHLs </plain></SENT>
<SENT sid="5" pm="."><plain>These findings suggested that disease progression in our novel murine <z:hpo ids='HP_0002665'>lymphoma</z:hpo> model may proceed via a Trp53-independent pathogenetic pathway </plain></SENT>
</text></document>